Cipla Limited (CIPLA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cipla Limited (CIPLA) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs13.45 Billion ≈ $145.49 Million USD) by net assets (Rs330.25 Billion ≈ $3.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CIPLA net asset quality index to measure how much of total assets are equity-financed.
Cipla Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Cipla Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Cipla Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Cipla Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cipla Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AKESO INC. O.N.
F:4RY
|
N/A |
|
Exelixis Inc
NASDAQ:EXEL
|
0.154x |
|
NIPPON YUSEN K.K.SP.DR1/5
F:NYK
|
N/A |
|
Revvity Inc.
NYSE:RVTY
|
0.016x |
|
BANKINTER ADR 2007 EO-30
F:BAK
|
N/A |
|
Tyler Technologies Inc
NYSE:TYL
|
0.030x |
|
Dongfang Electric Corp Ltd Class A
SHG:600875
|
-0.065x |
|
Taiwan Union Technology
TWO:6274
|
-0.087x |
Annual Cash Flow Conversion Efficiency for Cipla Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Cipla Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Cipla Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs312.89 Billion ≈ $3.38 Billion |
Rs50.05 Billion ≈ $541.27 Million |
0.160x | +3.71% |
| 2024-03-31 | Rs268.03 Billion ≈ $2.90 Billion |
Rs41.34 Billion ≈ $447.07 Million |
0.154x | +12.97% |
| 2023-03-31 | Rs237.14 Billion ≈ $2.56 Billion |
Rs32.38 Billion ≈ $350.14 Million |
0.137x | -13.31% |
| 2022-03-31 | Rs211.17 Billion ≈ $2.28 Billion |
Rs33.26 Billion ≈ $359.68 Million |
0.157x | -22.05% |
| 2021-03-31 | Rs185.86 Billion ≈ $2.01 Billion |
Rs37.55 Billion ≈ $406.11 Million |
0.202x | +5.73% |
| 2020-03-31 | Rs160.57 Billion ≈ $1.74 Billion |
Rs30.68 Billion ≈ $331.84 Million |
0.191x | +73.39% |
| 2019-03-31 | Rs153.44 Billion ≈ $1.66 Billion |
Rs16.91 Billion ≈ $182.89 Million |
0.110x | +9.87% |
| 2018-03-31 | Rs145.82 Billion ≈ $1.58 Billion |
Rs14.63 Billion ≈ $158.19 Million |
0.100x | -45.32% |
| 2017-03-31 | Rs129.82 Billion ≈ $1.40 Billion |
Rs23.82 Billion ≈ $257.58 Million |
0.183x | +25.06% |
| 2016-03-31 | Rs118.66 Billion ≈ $1.28 Billion |
Rs17.41 Billion ≈ $188.26 Million |
0.147x | +37.30% |
| 2015-03-31 | Rs109.82 Billion ≈ $1.19 Billion |
Rs11.73 Billion ≈ $126.90 Million |
0.107x | -40.73% |
| 2014-03-31 | Rs86.68 Billion ≈ $937.38 Million |
Rs15.63 Billion ≈ $169.00 Million |
0.180x | +16.34% |
| 2013-03-31 | Rs90.19 Billion ≈ $975.34 Million |
Rs13.98 Billion ≈ $151.15 Million |
0.155x | -30.88% |
| 2012-03-31 | Rs76.38 Billion ≈ $826.07 Million |
Rs17.13 Billion ≈ $185.23 Million |
0.224x | +45.08% |
| 2011-03-31 | Rs66.33 Billion ≈ $717.29 Million |
Rs10.25 Billion ≈ $110.86 Million |
0.155x | -12.42% |
| 2010-03-31 | Rs59.11 Billion ≈ $639.21 Million |
Rs10.43 Billion ≈ $112.80 Million |
0.176x | +104.69% |
| 2009-03-31 | Rs43.48 Billion ≈ $470.20 Million |
Rs3.75 Billion ≈ $40.54 Million |
0.086x | -11.79% |
| 2008-03-31 | Rs37.55 Billion ≈ $406.11 Million |
Rs3.67 Billion ≈ $39.69 Million |
0.098x | -5.42% |
| 2007-03-31 | Rs32.36 Billion ≈ $349.99 Million |
Rs3.34 Billion ≈ $36.17 Million |
0.103x | -26.06% |
| 2006-03-31 | Rs19.83 Billion ≈ $214.48 Million |
Rs2.77 Billion ≈ $29.97 Million |
0.140x | +8.56% |
| 2005-03-31 | Rs15.54 Billion ≈ $168.02 Million |
Rs2.00 Billion ≈ $21.63 Million |
0.129x | -35.24% |
| 2004-03-31 | Rs12.64 Billion ≈ $136.70 Million |
Rs2.51 Billion ≈ $27.17 Million |
0.199x | -- |
About Cipla Limited
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, suc… Read more